Loading Events

Genenta Science: Expert Perspectives: Immuno Gene & Cell Therapy for the Treatment of Solid Tumors

DATE: April 28, 2022
TIME: 8:00 AM EDT
LOCATION: N/A

About The Event

In this fireside chat, Genenta is delighted to bring together renowned neuro-oncologist David Reardon, MD (Harvard Medical School, Dana-Farber Cancer Institute) and Professor Luigi Naldini, MD, PhD (San Raffaele Telethon Institute for Gene Therapy), considered by many as the “father” of lentiviral gene therapy to discuss the potential application of immuno gene & cell therapy as a potential treatment for glioblastoma and other solid tumors. Genenta’s Temferon™, a lentivirus based hematopoietic stem progenitor cell immuno gene & cell therapy enabling controlled and targeted interferon-α expression within cancers, will be discussed as a potential treatment solution for glioblastoma patients.
Brad Loncar (CEO of Loncar Investments) will serve as the fireside chat moderator and Carlo Russo, MD (Genenta CMO & Head of Development) will also participate in the discussion.
A live question and answer session will follow.